Back to Search
Start Over
Corrigendum: EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation.
- Source :
-
Scientific Reports . 12/2/2016, p38270. 1p. - Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 20452322
- Database :
- Academic Search Index
- Journal :
- Scientific Reports
- Publication Type :
- Academic Journal
- Accession number :
- 119939936
- Full Text :
- https://doi.org/10.1038/srep38270